|
FY2026
12 months to Jun 30, 2026
|
FY2025
12 months to Jun 30, 2025
|
FY2024
12 months to Jun 30, 2024
|
FY2023
12 months to Jun 30, 2023
|
FY2022
12 months to Jun 30, 2022
|
|
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities | |||||
| (Gain) loss on disposal of assets | |||||
| Provision for uncollectible accounts | |||||
| Depreciation and amortization | |||||
| Operating lease rentals | |||||
| Loss (gain) on cost and equity method investments | |||||
| Impairments and loss on assets held for sale | |||||
| Amortization of deferred financing costs | |||||
| Stock-based compensation | |||||
| Deferred income taxes | |||||
| Other | |||||
| Changes in operating assets and liabilities, net of acquisitions | |||||
| Accounts receivable | |||||
| Prepaid expenses and other | |||||
| Income tax receivable | |||||
| Deposits and other | |||||
| Accounts payable and accrued expenses | |||||
| Reported and estimated claims | |||||
| Due to Medicaid and Medicare | |||||
| Income taxes payable | |||||
| Operating lease liabilities | |||||
| Deferred revenue | |||||
| Net cash provided by operating activities | |||||
| Investing Activities | |||||
| Purchases of property and equipment | |||||
| Purchases of short-term investments | |||||
| Proceeds from sale of short-term investments | |||||
| Proceeds from dissolution of equity method investments | |||||
| Acquisition of business | |||||
| Proceeds from sale of assets held for sale | |||||
| Net cash used in investing activities | |||||
| Financing Activities | |||||
| Payments for finance lease obligations | |||||
| Proceeds from long-term debt | |||||
| Principal payments on long-term debt | |||||
| Payment of debt issuance costs | |||||
| Repurchase of equity securities | |||||
| Contributions from joint venture partner | |||||
| Distributions to joint venture partner | |||||
| Taxes paid related to net settlements of stock-based compensation awards | |||||
| Net cash used in financing activities | |||||
| Net change in cash, cash equivalents and restricted cash including cash of $0.08 million reclassified to assets held for sale | |||||
| Less: change in cash and restricted cash reclassified to assets held for sale | |||||
| INCREASE IN CASH, CASH EQUIVALENTS & RESTRICTED CASH | |||||
| CASH, CASH EQUIVALENTS & RESTRICTED CASH, BEGINNING OF PERIOD | |||||
| CASH, CASH EQUIVALENTS & RESTRICTED CASH, END OF PERIOD | |||||
| Supplemental Cash Flows Information | |||||
| Interest paid | |||||
| Income taxes paid | |||||
| Property and equipment included in accounts payable | |||||
| Property and equipment purchased under capital leases | |||||
Loading...